2 high quality ASX dividend shares to buy to beat low rates

Wesfarmers Ltd (ASX:WES) and this ASX dividend share could be top options for income investors while rates remains at low levels…
The post 2 high quality ASX dividend shares to buy to beat low rates appeared first on The Motley Fool Australia. –

A hand moves a building block from green arrow to red, indicating negative interest rates

As I mentioned here earlier, the RBA will be meeting this afternoon to discuss the cash rate.

While there’s a chance it could cut rates to zero, Westpac Banking Corp (ASX: WBC) is tipping the central bank to make no changes and then keep rates on hold for some time to come.

Unfortunately, whichever way things go today, it seems inevitable that rates will be at ultra low levels for the foreseeable future.

With that in mind, if you’re an income investor, you might want to take a look at the dividend shares below. Here’s why they could be in the buy zone:

Sonic Healthcare Limited (ASX: SHL)

The first ASX dividend share to look at is Sonic Healthcare. It is a leading medical diagnostics company with operations across the world.

Sonic has been a very impressive performer during the pandemic thanks largely to strong demand for COVID-19 testing services. In fact, demand has been so strong, Sonic recently released its half year results and revealed a 33% increase in revenue to $4.4 billion and a whopping 166% increase in first half net profit to $678 million.

In response to this result, analysts at Citi put a buy rating and $37.50 price target on its shares. The broker is also forecasting dividends of $1.31 per share this year and then $1.40 per share in FY 2022.

Based on the latest Sonic share price of $31.85, this represents fully franked yields of 4.1% and 4.4%, respectively.

Wesfarmers Ltd (ASX: WES)

Another ASX dividend share to look at is Wesfarmers. As with Sonic, this conglomerate recently released its half year results and revealed strong revenue and profit growth.

For the six months ended 31 December, the company reported a 16.6% increase in revenue to $17,774 million and a 25.5% jump in net profit after tax to $1,414 million.

While the majority of Wesfarmers’ businesses performed positively during the half, the star of the show was its key Bunnings business. The hardware giant recorded an impressive 24.4% increase in revenue to $9,054 million.

Goldman Sachs was pleased with the result and appears to believe its growth can continue. The broker has a buy rating and $59.70 price target on its shares. It is also forecasting a fully franked full year dividend of $1.88 per share in FY 2021.

Based on the latest Wesfarmers share price of $50.73, this equates to a 3.7% yield.

These Dividend Stocks Could Be Your Next Cash Kings (FREE REPORT)

Motley Fool Australia’s Dividend experts recently released a brand-new FREE report revealing 3 dividend stocks with JUICY franked dividends that could keep paying you meaty dividends for years to come.

Our team of investors think these 3 dividend stocks should be a ‘must consider’ for any savvy dividend investor. But more importantly, could potentially make Australian investors a heap of passive income.

Don’t miss out! Simply click the link below to grab your free copy and discover these 3 high conviction stocks now.

Click Here For Your Free Stock Report

Returns As of 15th February 2021

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Wesfarmers Limited. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 high quality ASX dividend shares to buy to beat low rates appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!